Search

everythinglearnresearchcommunity

for

Search:↓

Folliculitis decalvans is a rare skin disease causing hair loss and requires personalized treatment.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

PHAT may improve hair growth better than PRP alone.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Ayurvedic treatments may help reduce hypothyroidism symptoms.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

PRP therapy for hair loss is safe but its effectiveness is doubtful.

A man with syphilitic alopecia and neurosyphilis was successfully treated with penicillin, leading to symptom improvement and resolution of hair loss.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Microneedling alone is as effective as microneedling with platelet-rich plasma for male pattern baldness.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

PRP injections did not significantly improve hair growth in men with androgenetic alopecia.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.